Analysts have set price targets and positive earnings estimate revisions for Day One Biopharmaceuticals (Q138859859) based on company expectations.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts have set price targets and positive earnings estimate revisions for Day One Biopharmaceuticals (Q138859859) based on company expectations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Day One Biopharmaceuticals (United States)
company in Brisbane, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksWall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade Day One Biopharmaceuticals, Inc. (DAWN) closed the last trading session at $6.94, gaining 7.